Uttar Pradesh News Desk

Neurodermatitis Market: Analysis of Epidemiology, Pipeline Therapies, and Key Companies Working in the Market|Key Companies Sanofi, Trevi Therapeutics, Galderma, Kiniksa Pharmaceuticals

 Breaking News
  • No posts were found

Neurodermatitis Market: Analysis of Epidemiology, Pipeline Therapies, and Key Companies Working in the Market|Key Companies Sanofi, Trevi Therapeutics, Galderma, Kiniksa Pharmaceuticals

April 11
20:28 2023
Neurodermatitis Market: Analysis of Epidemiology, Pipeline Therapies, and Key Companies Working in the Market|Key Companies Sanofi, Trevi Therapeutics, Galderma, Kiniksa Pharmaceuticals
DelveInsight Business Research LLP
DelveInsight’s “Neurodermatitis Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Neurodermatitis, historical and forecasted epidemiology as well as the Neurodermatitis market trends in the United States, EU4 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

DelveInsight’s Neurodermatitis Market Insights, Epidemiology, and Market Forecast-2032 report delivers an in-depth understanding of the Neurodermatitis, historical and forecasted epidemiology as well as the Neurodermatitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

The Neurodermatitis market report provides current treatment practices, emerging drugs, Neurodermatitis market share of the individual therapies, and current and forecasted Neurodermatitis market Size from 2019 to 2032 segmented by seven major markets. The Report also covers current Neurodermatitis treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the Neurodermatitis market.

Some of the key facts of Neurodermatitis Market Report:

  • In 2021, the total cases of Neurodermatitis in the 7MM countries were ~12,000, and these cases are anticipated to increase during the study period. The US accounted for 6,000 cases in 2021

  • Among the EU4 countries, Germany had the highest number of cases of PNH in 2021, i.e., ~ 1,300 cases, followed by France, which had ~ 900 cases in 2021. 

 Key Benefits of the Report:

  • The report covers a descriptive overview of Neurodermatitis, explaining its causes, signs and symptoms, pathophysiology, diagnosis, and currently available therapies

  • Comprehensive insight has been provided into the Neurodermatitis epidemiology and treatment in the 7MM

  • Additionally, an all-inclusive account of both the current and emerging therapies for Neurodermatitis is provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape

  • A detailed review of the Neurodermatitis market; historical and forecasted is included in the report, covering drug outreach in the 7MM

  • The report provides an edge while developing business strategies by understanding trends shaping and driving the global Neurodermatitis market

 Got queries? Click here to know more about the  Neurodermatitis Market Landscape 

 Neurodermatitis Overview

Neurodermatitis is a rare hematological disorder that results in episodic intravascular hemolysis, hemoglobinuria, hemolysis, and venous thrombosis. PNH is caused by somatic mutations in PIGA in one or more HSC clones. The gene product of PIGA has required for the biosynthesis of glycosylphosphatidylinositol (GPI) anchors; thus, PIGA mutations lead to a deficiency of GPI-anchored proteins, such as complement decay-accelerating factor (also known as CD55) and CD59 glycoprotein (CD59), which are both complement inhibitors. Erythrocytes lacking these proteins are exquisitely sensitive to complement‚Äźmediated intravascular hemolysis. PNH may occur de novo, but it is also associated with aplastic anemia and evolve into aplastic anemia after an indeterminate amount of time.

 

 Neurodermatitis Epidemiology Insights: 

  • In the case of the gender-specific prevalence of PNH, in 2021, females accounted for ~ 3,100 cases as compared to ~ 2,900 cases in males in the United States.

  • In EU4 and the UK countries, females accounted for more cases than males. In 2019, females accounted for ~ 3,000 cases, whereas males accounted for ~ 2,300 cases.

  • In the UK, males accounted for ~ 1,100 cases compared to ~ 1,400 cases in females in 2021.

  • In the case of the gender-specific prevalence of PNH, males accounted for ~ 500 cases as compared to ~ 400 cases in females in Japan in 2021.

 Neurodermatitis Epidemiological Segmentation 

  • Neurodermatitis prevalent cases 

  • Neurodermatitis incident cases 

  • Neurodermatitis diagnosed cases 

  • Neurodermatitis treatment cases 

Neurodermatitis Market Outlook 

The Neurodermatitis market outlook of the report helps to build a detailed comprehension of the historical, current and forecasted Neurodermatitis market trends by analyzing the impact of current Neurodermatitis therapies on the market, unmet needs, drivers and barriers, and demand for better technology.

This segment gives a thorough detail of the Neurodermatitis market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Neurodermatitis market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

According to DelveInsight, the Neurodermatitis market in 7MM is expected to witness a major change in the study period 2019-2032.

 Learn more by requesting for sample @ Neurodermatitis Market Landscape

 Neurodermatitis Key Companies

  • Sanofi 

  • Trevi Therapeutics 

  • Galderma 

  • Kiniksa Pharmaceuticals 

  • And many others 

Neurodermatitis Therapies 

  • Dupilumab SAR23189

 

Table of Contents

  1.  Key Insights 

  2.  Report Introduction 

  3.  Executive Summary of  Neurodermatitis Market 

  4.  Neurodermatitis Disease Background and Overview

  5.  Neurodermatitis Epidemiology and patient population

  6.  The United States 

  7.   EU 5

  8.  Neurodermatitis Market Emerging Therapies

  9.  Neurodermatitis Market Cancer Market Outlook

  10.  Market Access and Reimbursement of Therapies

  11.  Appendix

  12.  Neurodermatitis  Market Report Methodology

  13.  DelveInsight Capabilities

  14.  Disclaimer

  15. About DelveInsight

Click here to read more about Neurodermatitis Market Landscape 

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Adya Kaul
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services

Related Articles